Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Monday 04 March, 2013

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 2017Z
GlaxoSmithKline PLC
04 March 2013
 



 

Notification of Transactions of

Directors and Persons Discharging Managerial Responsibility

 

Vesting of conditional share awards made under

the GlaxoSmithKline Share Value Plan

 

This notification sets out the vesting of awards over Ordinary Shares made in 2010 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group.

 

The three-year vesting period for the 2010 SVP awards, which commenced on 23 February 2010, has now ended. The vesting of the SVP awards on 1 March 2013 made to individuals who have subsequently been appointed Persons Discharging Managerial Responsibility (PDMR), are given in the table below.

 

 

Name of PDMR

Number of Ordinary Shares vested

Mr R Connor

1,730

Mr P Thomson

1,730

Mr C Weber

4,590

Mrs V Whyte

1,730

 

The Company and PDMRs were advised of these transactions on 1 March 2013.

 

The fair market value of an Ordinary Share of GlaxoSmithKline plc at the point of vesting on 1 March 2013 was £14.55.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

V A Whyte

Company Secretary

 

4 March 2013


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSVZLFBXXFLBBL

a d v e r t i s e m e n t